Nam DH - Search Results

1

Comprehensive pharmacogenomic characterization of gastric cancer.

Sa JK, Hong JY, Lee IK, Kim JS, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM, Kim S, Kim KM, Kim ST, Park SH, Park JO, Lim HY, Kang WK, Her NG, Lee Y, Cho HJ, Shin YJ, Kim M, Koo H, Kim M, Seo YJ, Kim JY, Choi MG, Nam DH, Lee J. Sa JK, et al. Among authors: nam dh. Genome Med. 2020 Feb 18;12(1):17. doi: 10.1186/s13073-020-0717-8. Genome Med. 2020. PMID: 32070411 Free PMC article.

2

STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.

Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH. Jung HH, et al. Among authors: nam dh. FEBS Lett. 2005 Jul 18;579(18):3941-6. doi: 10.1016/j.febslet.2005.06.011. FEBS Lett. 2005. PMID: 15996661 Free article.

3

Mouse orthotopic lung cancer model induced by PC14PE6.

Cui ZY, Ahn JS, Lee JY, Kim WS, Lim HY, Jeon HJ, Suh SW, Kim JH, Kong WH, Kang JM, Nam DH, Park K. Cui ZY, et al. Among authors: nam dh. Cancer Res Treat. 2006 Dec;38(4):234-9. doi: 10.4143/crt.2006.38.4.234. Epub 2006 Dec 31. Cancer Res Treat. 2006. PMID: 19771249 Free PMC article.

4

Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.

Kong DS, Lee JI, Kim JH, Kim ST, Kim WS, Suh YL, Dong SM, Nam DH. Kong DS, et al. Among authors: nam dh. Neuro Oncol. 2010 Mar;12(3):289-96. doi: 10.1093/neuonc/nop030. Epub 2010 Jan 11. Neuro Oncol. 2010. PMID: 20167817 Free PMC article. Clinical Trial.

5

Wnt activation is implicated in glioblastoma radioresistance.

Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Kim Y, et al. Among authors: nam dh. Lab Invest. 2012 Mar;92(3):466-73. doi: 10.1038/labinvest.2011.161. Epub 2011 Nov 14. Lab Invest. 2012. PMID: 22083670 Free article.

6

Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.

Kim JY, Kim ST, Nam DH, Lee JI, Park K, Kong DS. Kim JY, et al. Among authors: nam dh. J Korean Neurosurg Soc. 2011 Oct;50(4):304-10. doi: 10.3340/jkns.2011.50.4.304. Epub 2011 Oct 31. J Korean Neurosurg Soc. 2011. PMID: 22200011 Free PMC article.

7

Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, Joo KM, Lee J, Nam DH. Kim KH, et al. Among authors: nam dh. Neuro Oncol. 2013 Feb;15(2):161-71. doi: 10.1093/neuonc/nos299. Epub 2012 Dec 20. Neuro Oncol. 2013. PMID: 23258844 Free PMC article.

8

Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.

Joo KM, Kim J, Jin J, Kim M, Seol HJ, Muradov J, Yang H, Choi YL, Park WY, Kong DS, Lee JI, Ko YH, Woo HG, Lee J, Kim S, Nam DH. Joo KM, et al. Among authors: nam dh. Cell Rep. 2013 Jan 31;3(1):260-73. doi: 10.1016/j.celrep.2012.12.013. Epub 2013 Jan 17. Cell Rep. 2013. PMID: 23333277 Free article.

9

Radiosensitization of brain metastasis by targeting c-MET.

Yang H, Lee HW, Kim Y, Lee Y, Choi YS, Kim KH, Jin J, Lee J, Joo KM, Nam DH. Yang H, et al. Among authors: nam dh. Lab Invest. 2013 Mar;93(3):344-53. doi: 10.1038/labinvest.2012.180. Epub 2013 Feb 4. Lab Invest. 2013. PMID: 23381625 Free article.

10

Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.

Lee HW, Joo KM, Lim JE, Cho HJ, Cho HJ, Park MC, Seol HJ, Seo SI, Lee JI, Kim S, Jeong BC, Nam DH. Lee HW, et al. Among authors: nam dh. Mol Cancer Res. 2013 Nov;11(11):1375-86. doi: 10.1158/1541-7786.MCR-13-0101-T. Epub 2013 Aug 27. Mol Cancer Res. 2013. PMID: 23982215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page